Literature DB >> 21793814

Relapse after systemic treatment in paediatric morphoea.

L Mirsky, A Chakkittakandiyil, R M Laxer, C O'Brien, E Pope.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21793814     DOI: 10.1111/j.1365-2133.2011.10535.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  11 in total

1.  Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort.

Authors:  Daniel Condie; Daniel Grabell; Heidi Jacobe
Journal:  Arthritis Rheumatol       Date:  2014-12       Impact factor: 10.995

2.  Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma.

Authors:  K L Kurzinski; C K Zigler; K S Torok
Journal:  Br J Dermatol       Date:  2018-12-05       Impact factor: 9.302

3.  [Localized scleroderma (morphea) in childhood].

Authors:  L Weibel
Journal:  Hautarzt       Date:  2012-02       Impact factor: 0.751

4.  Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.

Authors:  Suzanne C Li; Kathryn S Torok; Elena Pope; Fatma Dedeoglu; Sandy Hong; Heidi T Jacobe; C Egla Rabinovich; Ronald M Laxer; Gloria C Higgins; Polly J Ferguson; Andrew Lasky; Kevin Baszis; Mara Becker; Sarah Campillo; Victoria Cartwright; Michael Cidon; Christi J Inman; Rita Jerath; Kathleen M O'Neil; Sheetal Vora; Andrew Zeft; Carol A Wallace; Norman T Ilowite; Robert C Fuhlbrigge
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-08       Impact factor: 4.794

5.  Recurrence of morphea after successful ultraviolet A1 phototherapy: A cohort study.

Authors:  Rebecca Vasquez; Aysha Jabbar; Fatima Khan; Douglas Buethe; Chul Ahn; Heidi Jacobe
Journal:  J Am Acad Dermatol       Date:  2013-12-22       Impact factor: 11.527

6.  Risk factors for morphoea disease severity: a retrospective review of 114 paediatric patients.

Authors:  M S Pequet; K E Holland; S Zhao; B A Drolet; S S Galbraith; D H Siegel; Y E Chiu
Journal:  Br J Dermatol       Date:  2014-04       Impact factor: 9.302

Review 7.  Overview of Juvenile localized scleroderma and its management.

Authors:  Suzanne C Li; Rong-Jun Zheng
Journal:  World J Pediatr       Date:  2019-11-30       Impact factor: 2.764

Review 8.  Pediatric scleroderma: systemic or localized forms.

Authors:  Kathryn S Torok
Journal:  Pediatr Clin North Am       Date:  2012-04-06       Impact factor: 3.278

Review 9.  Localized scleroderma: clinical spectrum and therapeutic update.

Authors:  Mariana Figueiroa Careta; Ricardo Romiti
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

Review 10.  Morphea and Eosinophilic Fasciitis: An Update.

Authors:  Jorre S Mertens; Marieke M B Seyger; Rogier M Thurlings; Timothy R D J Radstake; Elke M G J de Jong
Journal:  Am J Clin Dermatol       Date:  2017-08       Impact factor: 7.403

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.